Evoke Pharma

EVOK NASDAQ
0.8875
+0.0075
+0.85%
After Hours: 0.8875 0 0.00% 17:24 08/19 EDT
Open
0.9164
Prev Close
0.8800
High
0.9200
Low
0.8710
Volume
162.81K
Avg Vol (3M)
775.81K
52 Week High
3.400
52 Week Low
0.5001
% Turnover
0.68%
Market Cap
21.40M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Evoke Pharma EVOK stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
MORE >

Recently

Name
Price
%Change